chithunzi
1066
chithunzi Language
chithunzi

Intravesical BCG Therapy for Bladder Cancer: Types, Procedure, Risks, Recovery and Cost in India

Gawani Kudzera pa:

Yawunikidwa ndi Gulu Lolemba la Apollo

Yankho lofulumira

Intravesical BCG therapy is a treatment for early bladder cancer that has not grown into the bladder muscle. A liquid containing BCG, a weakened bacterium, is placed directly into the bladder through a thin tube and held there for up to two hours. It stimulates the immune system in the bladder lining to attack remaining cancer cells. It is given weekly for six weeks after the tumour has been removed, usually followed by maintenance doses, and it lowers the chance of the cancer coming back or progressing.

Mfundo zazikuluzikulutsatanetsatane
Chomwe chiriImmunotherapy placed directly into the bladder
Zogwiritsidwa ntchitoNon-muscle-invasive bladder cancer at intermediate or high risk of returning, including carcinoma in situ
Pamene ikuyambaAt least two weeks after the tumour is removed through a cystoscope
NdandandaOnce a week for six weeks, then maintenance courses for one to three years
Time per visitThe instillation takes a few minutes; the liquid is held for up to two hours
OpaleshoniNone; a numbing gel is used for the catheter
Zotsatira zofalaBurning and frequent urination, mild fever and tiredness for a day or two
KatswiriUrologist or uro-oncologist

Doctor discussing intravesical BCG therapy for bladder cancer with an older man in a clinic

What is intravesical BCG therapy?

Intravesical means inside the bladder. BCG stands for Bacillus Calmette-Guerin, a live but weakened bacterium related to the one that causes tuberculosis. It is the same organism used in the BCG vaccine given to babies. When BCG is placed in the bladder, it sets off a local immune reaction in the lining. Immune cells gather there and destroy cancer cells that may have been left behind after surgery.

kwambiri bladder cancers are found early, when they are still in the inner lining of the bladder. These are called non-muscle-invasive bladder cancers. They are removed through the urethra using a telescope, an operation known as transurethral resection of bladder tumour (TURBT). Even after complete removal, these cancers often return, and some go on to invade the muscle. BCG is given to reduce both risks.

Because the treatment acts on the bladder lining and very little reaches the rest of the body, it does not cause the hair loss or low blood counts linked with mankhwala amphamvu given through a vein.

Other names for intravesical BCG therapy

  • BCG treatment for bladder cancer
  • BCG bladder instillation or bladder wash
  • Chithandizo cha immunotherapy m'mitsempha
  • Chithandizo cha BCG immunotherapy
  • Bacillus Calmette-Guerin therapy

Why is intravesical BCG therapy done?

After TURBT, the urologist places the cancer in a risk group based on the laboratory report. BCG is usually advised for:

  • High-grade tumours confined to the bladder lining.
  • Tumours that have grown into the layer just beneath the lining but not into the muscle.
  • Carcinoma in situ, a flat, high-grade form of early bladder cancer that cannot be fully removed by surgery alone.
  • Some intermediate-risk tumours, for example those that are large, multiple or have returned.

Low-risk tumours usually do not need BCG. Cancer that has grown into the bladder muscle needs different treatment, such as kuchotsa cystectomy yoopsa kwambiri or radiotherapy with chemotherapy, because BCG cannot reach deep enough.

Types of bladder instillation treatment

Phases of BCG therapy

  • Kubweretsa: One instillation a week for six weeks.
  • Kusungirako: Short courses of three weekly instillations, typically at three and six months and then every six months. Maintenance usually continues for one year in intermediate-risk disease and up to three years in high-risk disease, if it is tolerated.

The dose may be reduced if side effects are troublesome. At times BCG supplies are limited, and doctors may then adjust the schedule or suggest an alternative.

BCG compared with intravesical chemotherapy

mbaliIntravesical BCGIntravesical chemotherapy
Momwe ntchitoStimulates the immune system in the bladder liningKills cancer cells directly
Zogwiritsidwa ntchito makamakaHigh-risk and some intermediate-risk tumours, carcinoma in situLow-risk and intermediate-risk tumours; a single dose is often given soon after TURBT
Timing after TURBTNot before two weeksCan be given within hours
Kutalika kwa chithandizoInduction plus one to three years of maintenanceA single dose or a course over weeks to months
Zotsatira zoyipaBladder irritation and flu-like symptoms are common; rarely a BCG infectionBladder irritation and skin rash; generally milder
Not suitable ifWeak immune system, active infection, visible blood in urineBladder perforation is suspected after surgery

Who is suitable, and who may not be?

oyenera

Adults with non-muscle-invasive bladder cancer in the intermediate or high-risk group, whose tumour has been removed as completely as possible and whose bladder has had time to heal.

BCG should not be given, or should be postponed, if you have

  • Had TURBT or a bladder biopsy within the past two weeks.
  • Ziwoneka magazi mkodzo.
  • A urinary infection with symptoms or a fever.
  • A difficult or injuring catheter insertion on the day.
  • A weakened immune system, for example from HIV, some blood cancers, an organ transplant, or medicines that suppress immunity such as long-term steroids or chemotherapy.
  • yogwira chifuwa chachikulu.
  • A previous serious reaction to BCG.
  • Mimba kapena kuyamwitsa.

Having had the BCG vaccine or past exposure to tuberculosis does not prevent treatment.

Momwe mungakonzekerere

Kuyezetsa

  • The pathology report from TURBT. A second TURBT is often done for high-risk tumours before BCG begins.
  • A urine test before each dose, such as urinalysis kapena chikhalidwe cha mkodzo, to rule out infection.
  • Imaging of the kidneys and ureters, such as a CT urogram or ultrasound, if not already done.
  • Blood tests if your doctor advises them.

Things to tell your doctor

  • All medicines you take, especially steroids, medicines that suppress the immune system, blood thinners and water tablets.
  • Any antibiotics you are taking. Some antibiotics can weaken the effect of BCG.
  • Any artificial heart valve, joint replacement or other implant.
  • Fever, cough, burning urine or feeling unwell on the day.
  • Pregnancy or plans for pregnancy.

Patsikulo

  • Limit fluids for about four hours beforehand, and avoid tea and coffee that morning, so that you can hold the liquid comfortably.
  • Ask whether to delay your water tablet until after treatment.
  • Eat normally.
  • Pass urine just before the instillation.

How is intravesical BCG therapy performed?

  1. Lembetsani: The nurse or doctor asks about symptoms since the last dose and checks your urine sample. If there is infection or bleeding, the dose is postponed.
  2. Kuyika ndi kuyeretsa: You lie on a couch. The opening of the urethra is cleaned and a numbing gel is applied.
  3. Kuyika kwa Catheter: A thin, soft catheter is passed gently through the urethra into the bladder and any remaining urine is drained.
  4. Instillation: The BCG liquid, about a small cupful, is run slowly through the catheter into the bladder. This takes a few minutes.
  5. Kuchotsa Catheter: The catheter is usually removed straight away. Sometimes it is clamped and left in place.
  6. Holding the liquid: You try not to pass urine for up to two hours. You may be asked to change position now and then so the liquid coats the whole lining. Many people go home during this time. If you cannot hold it for the full period, tell the team; a shorter time still has some effect.
  7. Emptying the bladder: You pass urine into the toilet, sitting down to avoid splashing.

Chimachitika ndi chiyani pambuyo pake?

For six hours after each treatment, the urine contains live BCG. During this time:

  • Sit down to pass urine, including men.
  • Follow the hospital's instructions for disinfecting the toilet, which commonly involve adding household bleach, leaving it for about 15 minutes and then flushing with the lid down.
  • Wash your hands and genital area with soap and water after passing urine.
  • Wash any clothing that is splashed separately.
  • Drink plenty of fluids to flush the bladder.

Use a condom during sex, or avoid sex, for about a week after each instillation. Pregnancy should be avoided during the treatment period.

About six weeks to three months after the induction course, a cystoscopy ndi urine cytology are done to check the response, sometimes with biopsies.

Mavuto ndi mavuto

Common, usually settling within one to two days

  • Burning or stinging when passing urine.
  • Needing to pass urine often and urgently, features of chotupa.
  • A small amount of blood or debris in the urine.
  • Mild fever, chills, body ache and tiredness, like a mild flu.
  • Discomfort in the lower abdomen.

These effects often become more noticeable with later doses. They are signs of the immune reaction and can be eased with fluids and simple pain or fever medicine advised by your doctor.

Zosamveka

  • Bacterial urinary infection.
  • Inflammation of the prostate, or of the testicle and the tube behind it, causing pain and swelling.
  • Joint pains, skin rash or eye inflammation, a pattern like nyamakazi yogwira.
  • Narrowing of the urethra from repeated catheter use.
  • A small, stiff bladder after prolonged inflammation.

Zosowa koma zowopsa

  • BCG infection spreading to the blood or to organs such as the lungs or liver. It causes high, persistent fever and feeling very unwell, and needs urgent hospital treatment with anti-tuberculosis medicines. It is more likely if BCG is given when the bladder lining is injured, which is why doses are postponed after a difficult catheter insertion or when there is bleeding.
  • Severe allergic reaction.

Results: how well does it work?

BCG has been used for bladder cancer for several decades and remains the standard treatment after TURBT for high-risk non-muscle-invasive disease. Clinical trials have shown that it reduces the chance of the cancer returning compared with TURBT alone, and that maintenance treatment also lowers the risk of the cancer progressing into the muscle.

It does not work for everyone. In some people the cancer persists or returns despite adequate BCG. This is called BCG-unresponsive disease. Options then include removal of the bladder, which offers the best chance of cure in this situation, or other bladder-sparing treatments for those who cannot have or do not want surgery. Regular check cystoscopies are therefore as important as the BCG itself.

kuchira

There is no wound and no hospital stay. Most people rest on the day of treatment and return to work the next day. Bladder irritation and flu-like symptoms usually clear within 48 hours.

Nthawi yoti mupite kuchipatala

  • Fever above 38.5 degrees Celsius, or any fever lasting more than 48 hours.
  • Shaking chills, drenching sweats or feeling very unwell.
  • Heavy bleeding or clots in the urine, or inability to pass urine.
  • Burning and frequency that continue beyond two to three days.
  • Pain or swelling in a testicle.
  • New joint pain, rash, red or painful eyes.
  • Cough, breathlessness or yellowing of the eyes.

Always tell any doctor who sees you that you are receiving BCG, even if the problem appears months later.

Life after intravesical BCG therapy

  • Keep every cystoscopy appointment. Checks are usually every three months at first and less often later, and continue for years.
  • Stop smoking. Smoking is the main avoidable cause of bladder cancer and raises the chance of it returning.
  • Drink enough water through the day.
  • Report any new blood in the urine promptly, even if it is found only on a test.
  • Complete the maintenance course if you can tolerate it, and tell the team early if side effects are building up.
  • Tell your urologist before starting any medicine that affects immunity.
  • If you work with dyes, rubber or chemicals, follow workplace safety measures.

ubwino

  • Lowers the risk of early bladder cancer returning.
  • Maintenance treatment lowers the risk of progression to muscle-invasive cancer.
  • Helps many people keep their bladder.
  • Given in an outpatient clinic without anaesthesia.
  • Acts mainly in the bladder, so whole-body side effects are uncommon.

What is the cost of intravesical BCG therapy in India?

Mtengo wake umadalira zinthu zingapo:

  • The number of instillations, including maintenance courses
  • The dose used at each visit
  • Urine tests before each dose
  • Follow-up cystoscopies, cytology and biopsies
  • Mayesero ojambula
  • Treatment of any side effects or infection
  • Mzinda ndi chipatala

Mitengo imasiyana malinga ndi munthu aliyense. Chonde funsani kuchipatala kuti mudziwe mitengo yeniyeni.

Many health insurance policies cover bladder cancer treatment, but cover for outpatient instillations differs, so check with your insurer.

Why choose Apollo Hospitals for intravesical BCG therapy?

  • Urologists and uro-oncologists carry out TURBT, risk assessment and instillation treatment within one team.
  • Pathology, imaging and cystoscopy services are available for diagnosis and follow-up.
  • Trained nursing staff give instillations and explain home precautions.
  • Tumour boards review cases where BCG has not worked and discuss further options, including bladder removal surgery.
  • Emergency care is available for fever or other complications.

To discuss treatment for bladder cancer, you can book an appointment with a urologist ku Apollo Hospitals.

Kuwerenga kogwirizana

Questions to ask your doctor about intravesical BCG therapy

  • What is the risk group of my bladder cancer, and why is BCG advised?
  • Do I need a second TURBT before starting?
  • How many doses will I have, and how long will maintenance continue?
  • What should I do at home after each dose?
  • Which symptoms are expected, and which mean I should come to hospital?
  • Do any of my medicines or health conditions make BCG unsafe?
  • How will you check whether it has worked?
  • What are my options if the cancer returns after BCG?
  • What happens if BCG is not available on schedule?

Ibibazo

1. What does BCG do in bladder cancer?

BCG is a weakened bacterium that triggers an immune reaction in the bladder lining. The activated immune cells attack cancer cells left after the tumour is removed.

2. Is BCG therapy a type of chemotherapy?

No. It is a form of immunotherapy. It does not kill cancer cells directly and does not cause hair loss or the low blood counts seen with chemotherapy through a vein.

3. Kodi ndondomekoyi ndi yowawa?

Passing the catheter can be briefly uncomfortable, but a numbing gel is used. The liquid itself may cause a feeling of fullness or mild burning.

4. How long do I have to hold the BCG in my bladder?

Up to two hours. If you cannot manage that long, let the team know. Limiting fluids beforehand makes it easier.

5. How many BCG treatments will I need?

The induction course is six weekly doses. Maintenance consists of three weekly doses at set intervals for one to three years, depending on your risk group and how well you tolerate it.

6. Can I catch tuberculosis from BCG treatment?

BCG is weakened and does not cause tuberculosis in the usual sense. Rarely it can cause an infection in the body that is treated with anti-tuberculosis medicines. Report any persistent fever.

7. Is it safe for my family to be around me?

Yes. Normal contact, including hugging and sharing meals, is safe. The precautions apply to your urine for six hours after each dose and to sexual contact for about a week.

8. Why do I need to disinfect the toilet after treatment?

The urine contains live BCG for some hours. Disinfecting the toilet and washing your hands prevent other people from coming into contact with it.

9. Can I drive home after BCG?

Yes. No sedation is used, so most people can drive or travel home on their own.

10. Bwanji ndikaphonya mlingo?

Contact your urology team to reschedule. Doses are also postponed deliberately if you have an infection, bleeding or strong side effects. A short delay does not usually harm the result.

11. Do side effects mean the treatment is working?

Mild bladder irritation and flu-like symptoms reflect the immune reaction, but their absence does not mean the treatment has failed. The response is judged by cystoscopy and urine tests.

12. What happens if BCG does not work?

Your urologist will discuss further options. For high-risk cancer that persists or returns, removal of the bladder is often recommended. Other bladder-sparing treatments may be considered for selected people.

13. Can BCG be used for cancer that has grown into the bladder muscle?

No. BCG acts only on the lining. Muscle-invasive bladder cancer needs surgery, or radiotherapy with chemotherapy, often with chemotherapy first.

14. Which doctor performs intravesical BCG therapy?

A urologist or uro-oncologist prescribes and supervises it. The instillation is given by the urologist or a trained urology nurse in the outpatient clinic.

Kutsiliza

Intravesical BCG therapy is a long-established immunotherapy for early bladder cancer that carries a higher risk of returning. Placed directly in the bladder after the tumour is removed, it lowers the chance of recurrence and progression and helps many people keep their bladder. It requires commitment to a schedule of doses and check cystoscopies, simple precautions at home and prompt reporting of fever. If it does not control the cancer, your urology team will guide you on the next steps.

Tsamba ili ndi loti mudziwe zambiri ndipo sililowa m'malo mwa uphungu wochokera kwa dokotala wanu. Zisankho za chithandizo ziyenera kupangidwa ndi katswiri wodziwa bwino mbiri yanu yachipatala.

Urologists at Apollo Hospitals

Urology
Zaka 46+ MBBS, MS (Opaleshoni), MCh (Urology), DNB (Opaleshoni), DNB (Urology), FMGEMS - ECFMG
Urology
Zaka 42+ MBBS, MS, MCH, DNB
Urology
MBBS ya zaka 40+; MS (OPHUNZITSA KWAMBIRI); MCh. (UROLOGY)
Urology
Zaka 39+ MBBS, MS (Opaleshoni Yaikulu), MCh Urology
Urology
Zaka 38+ MBBS, MS (GENRAL SURGERY), Mch (UROLOGY)
Urology
35+ Years MBBS, Ph.D
Urology
MBBS ya zaka 33+; MS (OPHUNZITSIDWA KWAMBIRI); MCh. (UROLOGY); DNB (Urology); FRCS
Urology
Zaka 30+ MBBS, MS, FRCS, Dip mu Urology
×

Chodzikanira:

Zomwe zaperekedwa patsamba lino cholinga chake ndi kupereka chidziwitso ndi maphunziro okha. Ngakhale tikuyesetsa kuonetsetsa kuti chidziwitsocho ndi cholondola, chodalirika, komanso chowunikidwa nthawi zonse, sichiyenera kuonedwa ngati cholowa m'malo mwa upangiri wa akatswiri azachipatala, matenda, kapena chithandizo.

Kuyenerera kwa njira yachipatala, pamodzi ndi ubwino wake, zoopsa zake, kukonzekera, kuchira, mavuto omwe angakhalepo, ndi zotsatira zomwe zingayembekezeredwe, zingasiyane malinga ndi munthu aliyense. Katswiri wanu wazachipatala adzasankha ngati njirayo ndi yoyenera kutengera momwe mulili komanso mbiri yanu yachipatala.

Chonde funsani katswiri wodziwa bwino ntchito zachipatala kuti akupatseni upangiri musanapange chisankho chokhudza njira iliyonse yachipatala.

Kuti mudziwe zambiri za momwe zinthu zathu zachipatala zimapangidwira, kuunikidwanso, kusinthidwa, ndi kusamalidwa, chonde werengani [Ndondomeko Yolemba] yathu.

Chodzikanira: Izi ndi zongophunzitsa chabe osati m'malo mwa upangiri wachipatala. Nthawi zonse funsani dokotala wanu zokhudzana ndi zachipatala.

chithunzi chithunzi chithunzi
Pemphani Kuyimbiranso
Pemphani Kuyimbanso
Mtundu Wofunsira
Image
Doctor
Kusankhidwa kwa Bukhu
Kusankhidwa
Onani Kusankhidwa Kwamabuku
Image
zipatala
Pezani Chipatala
zipatala
Onani Pezani Chipatala
Chat
Image
kukayezetsa thanzi
Book Health Checkup
Macheke a Zaumoyo
Onani Mabuku Ofufuza Zaumoyo
Image
foni
Tiyitane
Tiyitane
Onani Imbani Ife
Image
Doctor
Kusankhidwa kwa Bukhu
Kusankhidwa
Onani Kusankhidwa Kwamabuku
Image
zipatala
Pezani Chipatala
zipatala
Onani Pezani Chipatala
Image
kukayezetsa thanzi
Book Health Checkup
Macheke a Zaumoyo
Onani Mabuku Ofufuza Zaumoyo
Image
foni
Tiyitane
Tiyitane
Onani Imbani Ife